Patents by Inventor Yun Qin

Yun Qin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240142305
    Abstract: A solar reflection full-band hyperspectral imaging detection system comprises a telescope light collection system, a field-of-view separation assembly, a spectrometer assembly, and a detector assembly. The field-of-view separation assembly comprises an integrated trisection field-of-view separator, a first field-of-view assembly, a second field-of-view assembly, and a third field-of-view assembly; the spectrometer assembly comprises a first spectrometer, a second spectrometer and a third spectrometer; and the detector assembly comprises a CMOS (Complementary Metal Oxide Semiconductor) detector, an InGaAs detector, and an HgCdTe detector. The present invention adopts the three-band spectrometer, and the spectrum aliasing, high photoelectric efficiency in the middle and low photoelectric efficiency at two ends, limited detection dynamic range, severe Etalon interference effect and the like of a two-band spectrometer with a traditional solar reflection full-band hyperspectral detection system are solved.
    Type: Application
    Filed: January 5, 2024
    Publication date: May 2, 2024
    Inventors: Yinnian LIU, Zongcun ZHANG, Rongjie QIN, Dexin SUN, Yun ZHAO, Youlong KE
  • Publication number: 20240100106
    Abstract: The present disclosure provides an isolated recombinant oncolytic adenovirus, a pharmaceutical composition, and uses thereof for drugs for treatment of tumors and/or cancers. The recombinant oncolytic adenovirus is a selectively replicating oncolytic adenovirus, and the genome of the recombinant oncolytic adenovirus is integrated with a coding sequence of exogenous shRNA capable of inhibiting PDL1 expression in tumor cells. The replication capability of the virus in normal primary cells is much lower than the replication capability of the virus in tumor cells. Moreover, the expressed shPDL1 can significantly reduce the level of PDL1 protein highly expressed in tumor cells. Thus, the oncolytic killing effect of the oncolytic virus and the anti-tumor immunostimulatory effect of immune cells produce a synergistic effect.
    Type: Application
    Filed: September 13, 2023
    Publication date: March 28, 2024
    Applicant: HANGZHOU CONVERD CO., LTD.
    Inventors: Jipo SHENG, Jin FU, Ronghua ZHAO, Yun QIN, Lin CHEN, Sanmao KANG, Fang HU
  • Patent number: 11929851
    Abstract: A gateway device selection method is provided. The method includes: receiving, by a terminal device, a message from a gateway device, where the message includes identification information of the gateway device, and the identification information of the gateway device indicates information about the gateway device; determining, by the terminal device, that the identification information of the gateway device is consistent with preset identification information of a gateway device on the terminal device, and using the gateway device as a selected gateway device; and sending, by the terminal device, a data packet to the selected gateway device. This helps the terminal device correctly identify the gateway device to which the terminal device is to send data.
    Type: Grant
    Filed: December 6, 2021
    Date of Patent: March 12, 2024
    Assignee: HUAWEI TECHNOLOGIES CO., LTD.
    Inventors: Yun Qin, Ling Wu
  • Patent number: 11806374
    Abstract: The present disclosure provides an isolated recombinant oncolytic adenovirus, a pharmaceutical composition, and uses thereof for drugs for treatment of tumors and/or cancers. The recombinant oncolytic adenovirus is a selectively replicating oncolytic adenovirus, and the genome of the recombinant oncolytic adenovirus is integrated with a coding sequence of exogenous shRNA capable of inhibiting PDL1 expression in tumor cells. The replication capability of the virus in normal primary cells is much lower than the replication capability of the virus in tumor cells. Moreover, the expressed shPDL1 can significantly reduce the level of PDL1 protein highly expressed in tumor cells. Thus, the oncolytic killing effect of the oncolytic virus and the anti-tumor immunostimulatory effect of immune cells produce a synergistic effect.
    Type: Grant
    Filed: July 3, 2018
    Date of Patent: November 7, 2023
    Assignee: HANGZHOU CONVERD CO., LTD.
    Inventors: Jipo Sheng, Jin Fu, Ronghua Zhao, Yun Qin, Lin Chen, Sanmao Kang, Fang Hu
  • Publication number: 20220124025
    Abstract: This application discloses a method for forwarding a packet in a data center network. A first device obtains an original packet, and adds a first source label to the original packet to obtain a first packet. The first source label includes a forwarding type, an indication field, and an interface sequence. The forwarding type indicates that the first packet supports source label forwarding, the interface sequence indicates a first source label forwarding path of the original packet, and the indication field indicates information that is about an outbound interface and that should be read from the interface sequence. The first device sends the first packet to a next-hop switch through the outbound interface corresponding to the first source label forwarding path. The next-hop switch receives the first packet, and forwards the first packet based on the first source label.
    Type: Application
    Filed: December 28, 2021
    Publication date: April 21, 2022
    Applicant: HUAWEI TECHNOLOGIES CO., LTD.
    Inventors: Fengkai LI, Yun QIN, Yinben XIA, Yashe LIU, Shengwei ZHENG, Shengwen LU, Yigang ZHOU
  • Publication number: 20220094572
    Abstract: A gateway device selection method is provided. The method includes: receiving, by a terminal device, a message from a gateway device, where the message includes identification information of the gateway device, and the identification information of the gateway device indicates information about the gateway device; determining, by the terminal device, that the identification information of the gateway device is consistent with preset identification information of a gateway device on the terminal device, and using the gateway device as a selected gateway device; and sending, by the terminal device, a data packet to the selected gateway device. This helps the terminal device correctly identify the gateway device to which the terminal device is to send data.
    Type: Application
    Filed: December 6, 2021
    Publication date: March 24, 2022
    Applicant: HUAWEI TECHNOLOGIES CO., LTD.
    Inventors: Yun QIN, Ling WU
  • Patent number: 11218339
    Abstract: A gateway device selection method is provided. The method includes: receiving, by a terminal device, a message from a gateway device, where the message includes identification information of the gateway device, and the identification information of the gateway device indicates information about the gateway device; determining, by the terminal device, that the identification information of the gateway device is consistent with preset identification information of a gateway device on the terminal device, and using the gateway device as a selected gateway device; and sending, by the terminal device, a data packet to the selected gateway device. This helps the terminal device correctly identify the gateway device to which the terminal device is to send data.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: January 4, 2022
    Assignee: HUAWEI TECHNOLOGIES CO., LTD.
    Inventors: Yun Qin, Ling Wu
  • Patent number: 11146952
    Abstract: The method includes: receiving, by a first member device, a second EAPOL-MKA packet sent by a second member device; determining, by the first member device, a first cipher suite, and determining a first secure association key SAK corresponding to the first cipher suite; and sending, by the first member device, the first cipher suite and the first SAK to the second member device in CA. Based on the foregoing technical solution, a device in the CA may determine a cipher suite and a secure association key corresponding to the cipher suite that are used for MACsec secure data transmission. In addition, all devices in the CA support the determined cipher suite. In this way, a problem that the cipher suite needs to be re-determined because one or more devices do not support the cipher suite determined by the first device can be avoided.
    Type: Grant
    Filed: February 17, 2019
    Date of Patent: October 12, 2021
    Assignee: HUAWEI TECHNOLOGIES CO., LTD.
    Inventors: De Sheng, Yun Qin
  • Publication number: 20210105348
    Abstract: Disclosed are a system, method and devices for simultaneous MACsec key agreement (MKA) negotiation between the devices. The present application controls a basic TLV message exchange between supplicant and authenticator in case of race condition to establish the secure association key (SAK) channel. The present application by controlling a basic TLV message exchange enables to establish a secure channel in race condition and achieves a high reliability of the product as this makes product launch MACsec services quickly and available for the service. Accordingly, when both sides (two supplicants) exchange hello with basic TLV at the same time, triggering the race condition, drops first message from the authenticator at supplicant and update the peer MN and the supplicant will not send reply. The authenticator when send next message (basic+potential peer TLV) with peer MN incremented by 1, the supplicant will respond with incremental message with live peer TLV.
    Type: Application
    Filed: December 16, 2020
    Publication date: April 8, 2021
    Inventors: Dharmanandana Reddy Pothula, Chandra Mohan Padamati, Antony Paul, Yun Qin, De Sheng
  • Patent number: 10904368
    Abstract: Disclosed are a system, method and devices for simultaneous MACsec key agreement (MKA) negotiation between the devices. The present application controls a basic TLV message exchange between supplicant and authenticator in case of race condition to establish the secure association key (SAK) channel. The present application by controlling a basic TLV message exchange enables to establish a secure channel in race condition and achieves a high reliability of the product as this makes product launch MACsec services quickly and available for the service. Accordingly, when both sides (two supplicants) exchange hello with basic TLV at the same time, triggering the race condition, drops first message from the authenticator at supplicant and update the peer MN and the supplicant will not send reply. The authenticator when send next message (basic+potential peer TLV) with peer MN incremented by 1, the supplicant will respond with incremental message with live peer TLV.
    Type: Grant
    Filed: May 23, 2019
    Date of Patent: January 26, 2021
    Assignee: Huawei Technologies Co., Ltd.
    Inventors: Dharmanandana Reddy Pothula, Chandra Mohan Padamati, Antony Paul, Yun Qin, De Sheng
  • Publication number: 20200276252
    Abstract: The present disclosure provides an isolated recombinant oncolytic adenovirus, a pharmaceutical composition, and uses thereof for drugs for treatment of tumors and/or cancers. The recombinant oncolytic adenovirus is a selectively replicating oncolytic adenovirus, and the genome of the recombinant oncolytic adenovirus is integrated with a coding sequence of exogenous shRNA capable of inhibiting PDL1 expression in tumor cells. The replication capability of the virus in normal primary cells is much lower than the replication capability of the virus in tumor cells. Moreover, the expressed shPDL1 can significantly reduce the level of PDL1 protein highly expressed in tumor cells. Thus, the oncolytic killing effect of the oncolytic virus and the anti-tumor immunostimulatory effect of immune cells produce a synergistic effect.
    Type: Application
    Filed: July 3, 2018
    Publication date: September 3, 2020
    Inventors: Jipo SHENG, Jin FU, Ronghua ZHAO, Yun QIN, Lin CHEN, Sanmao KANG, Fang HU
  • Publication number: 20200079565
    Abstract: This invention provides a blister pack comprising a base sheet having a plurality of blisters formed therein, each of which has an opening and is configured for containing a unit dose of a deformable or fragile product, with a lid sheet attached to said base sheet for covering the openings of said blisters. The blister pack further comprises a reinforcing sheet with cut-out sections that form ledges near said blister openings. Such ledges can be used for cutting the lid sheet at said blister openings and releasing the unit doses of said deformable or fragile product.
    Type: Application
    Filed: September 6, 2019
    Publication date: March 12, 2020
    Inventors: Stefano BARTOLUCCI, Yun Qin LEE, William Mercer BENSON, Nathan Daniel GRUBBS
  • Patent number: 10523507
    Abstract: Method and a server system for tuning a performance of an application are disclosed. A plurality of traffic flows associated with user requests related to the application are monitored for a predefined sampling period. A traffic flow associated with a highest total volume of communication is identified from among the plurality of traffic flows. The identified traffic flow is used for selecting corresponding flow segments in a decreasing order of respective individual volume of communication. For each selected flow segment, a pair of microservice instances is identified. It is determined whether at least one microservice instance is capable of being relocated from a respective current host to another host for achieving at least one predetermined performance objective. A redeployment of the at least one microservice instance is facilitated if the at least one microservice instance is capable of being relocated from the current host to another host.
    Type: Grant
    Filed: April 27, 2018
    Date of Patent: December 31, 2019
    Assignee: Nirmata, Inc.
    Inventors: Damien Toledo, Jamsheed Bugwadia, Yun Qin
  • Publication number: 20190281031
    Abstract: Disclosed are a system, method and devices for simultaneous MACsec key agreement (MKA) negotiation between the devices. The present application controls a basic TLV message exchange between supplicant and authenticator in case of race condition to establish the secure association key (SAK) channel. The present application by controlling a basic TLV message exchange enables to establish a secure channel in race condition and achieves a high reliability of the product as this makes product launch MACsec services quickly and available for the service. Accordingly, when both sides (two supplicants) exchange hello with basic TLV at the same time, triggering the race condition, drops first message from the authenticator at supplicant and update the peer MN and the supplicant will not send reply. The authenticator when send next message (basic+potential peer TLV) with peer MN incremented by 1, the supplicant will respond with incremental message with live peer TLV.
    Type: Application
    Filed: May 23, 2019
    Publication date: September 12, 2019
    Inventors: Dharmanandana Reddy Pothula, Chandra Mohan Padamati, Antony Paul, Yun Qin, De Sheng
  • Patent number: D898586
    Type: Grant
    Filed: March 12, 2019
    Date of Patent: October 13, 2020
    Assignee: The Procter & Gamble Company
    Inventors: Yun Qin Lee, Stefano Bartolucci
  • Patent number: D965440
    Type: Grant
    Filed: December 7, 2020
    Date of Patent: October 4, 2022
    Assignee: The Procter and Gamble Company
    Inventors: Yun Qin Lee, Toshiyuki Okada
  • Patent number: D1011909
    Type: Grant
    Filed: December 13, 2019
    Date of Patent: January 23, 2024
    Assignee: The Procter & Gamble Company
    Inventors: U-Ping Loh, Yun Qin Lee, Caroline Colin
  • Patent number: D1017895
    Type: Grant
    Filed: March 12, 2019
    Date of Patent: March 12, 2024
    Assignee: The Procter & Gamble Company
    Inventor: Yun Qin Lee
  • Patent number: D1018968
    Type: Grant
    Filed: March 16, 2021
    Date of Patent: March 19, 2024
    Assignee: The Procter & Gamble Company
    Inventors: Li Tang, Yun Qin Lee
  • Patent number: D1022458
    Type: Grant
    Filed: November 30, 2023
    Date of Patent: April 16, 2024
    Inventor: Yun Qin